Top

Published in:

01-12-2009 | Review Article

Can Improving Sleep Influence Sleep-Disordered Breathing?

Author: Dr Frédéric Sériès

Published in: Drugs | Special Issue 2/2009

Abstract

Sleep-disordered breathing (SDB) encompasses a group of disorders that include obstructive sleep apnoea (OSA), central sleep apnoea (CSA) and nocturnal hypoventilation. SDB commonly coexists with sleep disorders such as insomnia and restless legs syndrome, and sleep deprivation has been shown to play a role in the pathogenesis of SDB. Participants of a workshop, held at the 6th annual meeting of The International Sleep Disorders Forum: The Art of Good Sleep in 2008, evaluated whether the effective management of sleep disorders could result in a reduction in SDB. Following the workshop, a critical review of the literature in the field of sleep and SDB was conducted in order to assess the impact of improving sleep on SDB, and to determine whether measures taken to improve sleep result in a subsequent improvement in SDB. Results showed that studies evaluating the influence of improved sleep on respiratory abnormalities in patients with SDB are lacking. Studies in patients with OSA, with or without obesity-hypoventilation syndrome, show that therapy with continuous positive airways pressure and non-invasive ventilation improves sleep parameters with beneficial effects on SDB. Studies involving small numbers of patients have shown that the antidepressants fluoxetine and mirtazapine produce improvements in sleep parameters and the apnoea-hypopnoea index, and that acetazolamide may improve CSA. The benzodiazepines flurazepam, temazepam and nitrazepam, the hypnotic zolpidem, the melatonin receptor agonist ramelteon and gamma-hydroxybutyrate have all been shown to improve sleep, but are not associated with reductions or worsening in SDB. It is clear that there is a distinct knowledge gap with regard to the benefit of improving sleep disturbances for subsequent improvements in SDB. Randomized controlled clinical trials investigating the effect of pharmacological and non-pharmacological improvement of sleep disorders focusing on whether there is improvement in coexisting OSA/SDB are clearly needed. Furthermore, well-designed clinical trials investigating the role of hypnotic agents in improving SDB in certain phenotypes will enable the development of treatment recommendations for primary care physicians managing these patients in routine clinical practice.

Wellman A, Jordan AS, Malhotra A, et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170: 1225–32PubMedCrossRef

Aeschbach D, Cutler AJ, Ronda JM. A role for non-rapid-eye-movement sleep homeostasis in perceptual learning. J Neurosci 2008; 28: 2766–72PubMedCrossRef

Motivala SJ, Tomiyama AJ, Ziegler M, et al. Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology 2009; 34: 540–5PubMedCrossRef

Dijk DJ. Slow-wave sleep, diabetes, and the sympathetic nervous system. Proc Natl Acad Sci U S A 2008; 105: 1107–8PubMedCrossRef

Ohayon MM. Difficulty in resuming or inability to resume sleep and the links to daytime impairment: Definition, prevalence and comorbidity. J Psychiatr Res 2009; 43: 934–40PubMedCrossRef

Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring) 2008; 16: 643–53CrossRef

Tasali E, Leproult R, Ehrmann DA, et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 2008; 105: 1044–9PubMedCrossRef

Ohayon MM. Nocturnal awakenings and comorbid disorders in the American general population. J Psychiatr Res 2008; 43: 48–54PubMedCrossRef

Eckert DJ, Jordan AS, Merchia P, et al. Central sleep apnea: Pathophysiology and treatment. Chest 2007; 131: 595–607PubMedCrossRef

10.

Al-Alawi A, Mulgrew A, Tench E, et al. Prevalence, risk factors and impact on daytime sleepiness and hypertension of periodic leg movements with arousals in patients with obstructive sleep apnea. J Clin Sleep Med 2006; 2: 281–7PubMed

11.

Chervin RD. Periodic leg movements and sleepiness in patients evaluated for sleep-disordered breathing. Am J Respir Crit Care Med 2001; 164: 1454–8PubMed

12.

Chung KF. Insomnia subtypes and their relationships to daytime sleepiness in patients with obstructive sleep apnea. Respiration 2005; 72: 460–5PubMedCrossRef

13.

Ohayon MM, Li KK, Guilleminault C. Risk factors for sleep bruxism in the general population. Chest 2001; 119: 53–61PubMedCrossRef

14.

Sjoholm TT, Lowe AA, Miyamoto K, et al. Sleep bruxism in patients with sleep-disordered breathing. Arch Oral Biol 2000; 45: 889–96PubMedCrossRef

15.

Krell SB, Kapur VK. Insomnia complaints in patients evaluated for obstructive sleep apnea. Sleep Breath 2005; 9: 104–10PubMedCrossRef

16.

Lavie P. Insomnia and sleep-disordered breathing. Sleep Med 2007; 8 (Suppl. 4): S21–5PubMedCrossRef

17.

Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008; 9: 425–32PubMedCrossRef

18.

Leiter JC, Knuth SL, Bartlett D Jr. The effect of sleep deprivation on activity of the genioglossus muscle. Am Rev Respir Dis 1985; 132: 1242–5PubMed

19.

Desai AV, Marks G, Grunstein R. Does sleep deprivation worsen mild obstructive sleep apnea? Sleep 2003; 26: 1038–41PubMed

20.

Series F, Roy N, Marc I. Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects. Am J Respir Crit Care Med 1994; 150: 481–5PubMed

21.

Berry RB, Kouchi K, Bower J, et al. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151:450–4PubMed

22.

Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007; 132:440–6PubMedCrossRef

23.

Camacho ME, Morin CM. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 1995; 18: 644–5PubMed

24.

Carley DW, Olopade C, Ruigt GS, et al. Efficacy of mirta-zapine in obstructive sleep apnea syndrome. Sleep 2007; 30: 35–41PubMed

25.

de Lucas-Ramos P, de Miguel-Diez J, Santacruz-Siminiani A, et al. Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Respir Med 2004; 98: 961–7PubMedCrossRef

26.

Piper AJ, Sullivan CE. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994; 105: 434–40PubMedCrossRef

27.

Krakow B, Melendrez D, Sisley B, et al. Nasal dilator strip therapy for chronic sleep-maintenance insomnia and symptoms of sleep-disordered breathing: a randomized controlled trial. Sleep Breath 2006; 10: 16–28PubMedCrossRef

28.

Noseda A, Nouvelle M, Lanquart JR, et al. High leg motor activity in sleep apnea hypopnea patients: efficacy of clona-zepam combined with nasal CPAP on polysomnographic variables. Respir Med 2002; 96: 693–9PubMedCrossRef

29.

Freire AO, Sugai GC, Chrispin FS, et al. Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Med 2007; 8: 43–50PubMedCrossRef

30.

Guimarães KC, Drager LF, Genta PR, et al. Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2009; 179: 962–6PubMedCrossRef

31.

Loredo JS, Ancoli-Israel S, Kim EJ, et al. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep 2006; 29: 564–71PubMed

32.

Puhan MA, Suarez A, Lo Cascio C, et al. Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trial. BMJ 2006; 332: 266–70PubMedCrossRef

33.

Siccoli MM, Pepperell JC, Kohler M, et al. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008; 31: 1551–8PubMed

34.

Banerjee D, Yee BJ, Piper AJ, et al. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest 2007; 131: 1678–84PubMedCrossRef

35.

Chouri-Pontarollo N, Borel JC, Tamisier R, et al. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest 2007; 131: 148–55PubMedCrossRef

36.

Piper AJ, Wang D, Yee BJ, et al. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 2008; 63: 395–401PubMedCrossRef

37.

Franklin KA, Eriksson P, Sahlin C, et al. Reversal of central sleep apnea with oxygen. Chest 1997; 111: 163–9PubMedCrossRef

38.

Ruttanaumpawan P, Logan AG, Floras JS, et al. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep 2009; 32: 91–8PubMed

39.

To KW, Chan WC, Choo KL, et al. A randomized crossover study of auto-continuous positive airway pressure versus fixed-continuous positive airway pressure in patients with obstructive sleep apnoea. Respirology 2008; 13: 79–86PubMed

40.

Smith I, Nadig V, Lasserson TJ. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines for adults with obstructive sleep apnoea. Cochrane Database Syst Rev 2009: CD007736

41.

Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 5: 173–8PubMedCrossRef

42.

Suzuki M, Saigusa H, Furukawa T. Comparison of sleep parameters at titration and subsequent compliance between CPAP-pretreated and non-CPAP-pretreated patients with obstructive sleep apnea. Sleep Med 2007; 8: 773–8PubMedCrossRef

43.

Richards D, Bartlett DJ, Wong K, et al. Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial. Sleep 2007; 30: 635–40PubMed

44.

Kopelman PG, Elliott MW, Simonds A, et al. Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation. Int J Obes Relat Metab Disord 1992; 16: 825–30PubMed

45.

Berry RB, Patel PB. Effect of zolpidem on the efficacy of continuous positive airway pressure as treatment for obstructive sleep apnea. Sleep 2006; 29: 1052–6PubMed

46.

Bonnet MH, Dexter JR, Arand DL. The effect of triazolam on arousal and respiration in central sleep apnea patients. Sleep 1990; 13: 31–41PubMed

47.

Collen J, Lettieri C, Kelly W, et al. Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance. Chest 2009; 135: 704–9PubMedCrossRef

48.

Cirignotta F, Mondini S, Zucconi M, et al. Zolpidem-poly-somnographic study of the effect of a new hypnotic drug in sleep apnea syndrome. Pharmacol Biochem Behav 1988; 29: 807–9PubMedCrossRef

49.

Hoijer U, Hedner J, Ejnell H, et al. Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J 1994; 7: 2011–5PubMed

50.

Lettieri CJ, Quast TN, Eliasson AH, et al. Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial. Sleep 2008; 31: 1310–6PubMed

51.

Steens RD, Pouliot Z, Millar TW, et al. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 1993; 16: 318–26PubMed

52.

Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006; 173: 234–7PubMedCrossRef

53.

Kryger M, Wang-Weigand S, Roth T. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep Breath 2007; 11: 159–64PubMedCrossRef

54.

Kryger M, Wang-Weigand S, Zhang J, et al. Effect of ramelteon, a selective MT(1)/MT(2)-receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep Breath 2008; 12: 243–50PubMedCrossRef

55.

Kryger M, Roth T, Wang-Weigand S, et al. The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. Sleep Breath 2009; 13: 79–84PubMedCrossRef

56.

Saletu-Zyhlarz G, Anderer P, Gruber G, et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003; 12: 239–54PubMedCrossRef

57.

Series F, Series I, Cormier Y. Effects of enhancing slow-wave sleep by gamma-hydroxybutyrate on obstructive sleep apnea. Am Rev Respir Dis 1992; 145: 1378–83PubMed

58.

Yee BJ, Phillips CL, Banerjee D, et al. The effect of sibu-tramine-assisted weight loss in men with obstructive sleep apnoea. Int J Obes (Lond) 2007; 31: 161–8CrossRef

59.

Ferland A, Poirier P, Series F. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. Eur Respir J 2009; 34: 694–701PubMedCrossRef

60.

Fenik P, Veasey SC. Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus. Am J Respir Crit Care Med 2003; 167: 563–9PubMedCrossRef

61.

Sood S, Morrison JL, Liu H, et al. Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats. Am J Respir Crit Care Med 2005; 172: 1338–47PubMedCrossRef

62.

Veasey SC, Fenik P, Panckeri K, et al. The effects of trazo-done with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 1999; 160: 1659–67PubMed

63.

Veasey SC, Panckeri KA, Hoffman EA, et al. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med 1996; 153: 776–86PubMed

64.

DeBacker WA, Verbraecken J, Willemen M, et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995; 151: 87–91PubMed

65.

Fischer R, Lang SM, Leitl M, et al. Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude. Eur Respir J 2004; 23: 47–52PubMedCrossRef

66.

Metcalf DR, Emde RN, Stripe JT. An EEG-behavioral study of sodium hydroxybutyrate in humans. Electro-encephalogr Clin Neurophysiol 1966; 20: 506–12CrossRef

67.

Broughton R, Mamelak M. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy. Can J Neurol Sci 1980; 7: 23–31PubMed

68.

Seeck-Hirschner M, Baier PC, von Freier A, et al. Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports. Sleep Med 2009; 10: 154–5PubMedCrossRef

69.

Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230–5PubMedCrossRef

70.

Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015–21PubMedCrossRef

71.

Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103: 850–5PubMed

72.

Martinez D, Basile BR. Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study. Sleep Med 2005; 6: 467–70PubMedCrossRef

73.

Heinzer RC, White DP, Jordan AS, et al. Trazodone increases arousal threshold in obstructive sleep apnoea. Eur Respir J 2008; 31: 1308–12PubMedCrossRef

74.

Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991; 100: 416-21PubMedCrossRef

Title: Can Improving Sleep Influence Sleep-Disordered Breathing?
Author: Dr Frédéric Sériès
Publication date: 01-12-2009
Publisher: Springer International Publishing
Published in: Drugs / Issue Special Issue 2/2009
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI: https://doi.org/10.2165/11532000-000000000-00000

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Can Improving Sleep Influence Sleep-Disordered Breathing?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2009

Does Effective Management of Sleep Disorders Reduce Cancer-Related Fatigue?

Does Effective Management of Sleep Disorders Reduce Substance Dependence?

Foreword

Does Effective Management of Sleep Disorders Reduce Depressive Symptoms and the Risk of Depression?

Does Effective Management of Sleep Disorders Improve Pain Symptoms?

Do Sleep Disorders and Associated Treatments Impact Glucose Metabolism?